Medication info
Hanapramidine Tablet

Hanapramidine Tablet

Prescription medicationTablet
Ingredient · strength
Famotidine›20mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
500 tablets/bottle
Approval status
Active

MFDS item code 199501906 · Notified 1995.03.31 · Insurance code 657802850

Summary

Main use
Treatment of gastrointestinal disorders (e.g., ulcers, bleeding), pre-anesthetic medication, and improvement of gastric mucosal lesions
Who uses it
Adults
Adult dosage
(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults should take famotidine 20mg orally twice daily (after breakfast, after dinner, or at bedtime), or 40mg orally once daily (at bedtime). For upper gastrointestinal bleeding, treatment is usually initiated with an injection, and switched to oral administration once oral administration becomes possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis, acute exacerbation of chronic gastritis Adults should take famotidine 10mg orally twice daily (after breakfast, after dinner, or at bedtime), or 20mg orally once daily (at bedtime). The dose may be adjusted appropriately according to age and symptoms. (Injection) Adults: Dissolve famotidine 20mg in 20ml of normal saline injection or dextrose injection and administer slowly by intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, effects generally appear within 1 week. Switch to oral administration once oral administration becomes possible. For preanesthetic medication, dissolve 20mg in 1-1.5ml of water for injection and administer by intramuscular injection 1 hour before induction of anesthesia, or dissolve in 20ml of normal saline injection or dextrose injection and administer slowly by intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours if stored at room temperature or refrigerated. The dose may be adjusted appropriately according to age and symptoms.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (e.g., ulcers, bleeding), pre-anesthetic medication, and improvement of gastric mucosal lesions

  • Gastric ulcer
  • duodenal ulcer
  • anastomosis ulcer
  • upper gastrointestinal bleeding
  • acute stress ulcer
  • hemorrhagic gastritis
  • gastroesophageal reflux disease
  • Zollinger-Ellison syndrome
  • gastric mucosal erosion
  • gastric mucosal bleeding
  • gastric mucosal erythema
  • gastric mucosal swelling
View approved original text

This medication is primarily used for diseases involving gastric and duodenal ulcers, anastomosis ulcers, and upper gastrointestinal bleeding. It is also effective for the treatment of gastroesophageal reflux disease and Zollinger-Ellison syndrome, and improves mucosal damage (erosion, bleeding, erythema, swelling) associated with both acute and chronic gastritis. It is available in both oral and injectable forms, allowing for administration according to the specific situation, and injections are also used prior to anesthesia. This medication helps improve gastric mucosal lesions and alleviate bleeding, thus promoting gastrointestinal health.

Dosage and Administration

Adult dosage

(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults should take famotidine 20mg orally twice daily (after breakfast, after dinner, or at bedtime), or 40mg orally once daily (at bedtime). For upper gastrointestinal bleeding, treatment is usually initiated with an injection, and switched to oral administration once oral administration becomes possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis, acute exacerbation of chronic gastritis Adults should take famotidine 10mg orally twice daily (after breakfast, after dinner, or at bedtime), or 20mg orally once daily (at bedtime). The dose may be adjusted appropriately according to age and symptoms. (Injection) Adults: Dissolve famotidine 20mg in 20ml of normal saline injection or dextrose injection and administer slowly by intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, effects generally appear within 1 week. Switch to oral administration once oral administration becomes possible. For preanesthetic medication, dissolve 20mg in 1-1.5ml of water for injection and administer by intramuscular injection 1 hour before induction of anesthesia, or dissolve in 20ml of normal saline injection or dextrose injection and administer slowly by intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours if stored at room temperature or refrigerated. The dose may be adjusted appropriately according to age and symptoms.

Precautions

This medication should not be used in patients who are allergic to the ingredients or H2 receptor antagonists. It also contains lactose, so it should not be administered to patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Patients with a history of drug allergies or impaired kidney function should use this medication with caution. Patients with heart disease or liver dysfunction should also use this medication carefully, and the dosage interval should be extended for the elderly. This medication can rarely cause serious allergic reactions, blood disorders, skin diseases, liver dysfunction, muscle damage, cardiac rhythm abnormalities, and kidney problems; if any unusual symptoms occur, stop using it immediately and seek medical attention. Additionally, various side effects such as rash, hives, dyspepsia, blood pressure changes, respiratory problems, and neurological disturbances may occur, so caution is necessary. During treatment, continuously observe symptoms and blood, liver, and kidney function, and consider switching to another treatment if there is no effect. This medication dissolves in the mouth but is not absorbed through the oral mucosa; it must be swallowed with saliva or water. Patients undergoing dialysis should be cautious as the efficacy of some medications may be reduced when used with phosphate binders. If used with certain antifungal agents or specific chemotherapy drugs, the efficacy of this medication or other medications may be reduced, so consultation with a physician is necessary. Women who are pregnant or of childbearing potential should use this medication carefully, and breastfeeding women are advised to discontinue breastfeeding. The safety for pediatric use has not been thoroughly verified, so caution is required. The oral disintegrating tablet form of this medication should be placed on the tongue, allowed to dissolve with saliva, and swallowed; it should not be taken lying down without water. Finally, this medication may mask symptoms of gastric cancer, so it should be used only after confirming the malignancy status.

Side effects

  • shock
  • hypersensitivity
  • anaphylaxis
  • respiratory distress
  • systemic flushing
  • angioedema
  • facial edema
  • pharyngeal edema
  • urticaria
  • pancytopenia
Show 85 more
  • agranulocytosis
  • aplastic anemia
  • hemolytic anemia
  • thrombocytopenia
  • general malaise
  • weakness
  • subcutaneous hemorrhage
  • mucosal hemorrhage
  • fever
  • Stevens-Johnson syndrome
  • Lyell's syndrome
  • liver dysfunction
  • jaundice
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • elevated serum muscle enzymes
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • altered consciousness
  • generalized seizures
  • rigid seizures
  • clonic seizures
  • interstitial nephritis
  • acute kidney failure
  • fever
  • rash
  • abnormal renal function test results
  • interstitial pneumonia
  • high fever
  • cough
  • respiratory distress
  • abnormal chest X-ray
  • inadequate contraction
  • rash
  • urticaria
  • erythema
  • facial flushing
  • leukopenia
  • eosinophilia
  • constipation
  • diarrhea
  • soft stools
  • thirst
  • nausea
  • vomiting
  • abdominal distension
  • anorexia
  • stomatitis
  • hypertension
  • tinnitus
  • bradycardia
  • tachycardia
  • heart block
  • bronchospasm
  • elevated AST
  • elevated ALT
  • elevated ALP
  • elevated total bilirubin
  • elevated LDH
  • hepatitis
  • general malaise
  • lethargy
  • headache
  • drowsiness
  • insomnia
  • hallucinations
  • anxiety
  • agitation
  • decreased libido
  • sensory disturbances
  • heaviness in the head
  • reversible confusional state
  • depression
  • seizures
  • dizziness
  • menstrual irregularities
  • gynecomastia
  • arthralgia
  • elevated CK
  • altered taste
  • muscle cramps

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. Additionally, it should be kept out of direct sunlight and stored in a general room temperature area, which should not be too hot or too cold.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.